Objectives

After participating in this educational activity, attendees should be able to:
1. Recognize the value of identifying a cancer predisposition syndrome.
2. Recognize cancer predisposition syndromes including Li-Fraumeni syndrome and DICER1 syndrome.
3. Describe how the landscape of germline testing, risk assessment and screening are evolving and areas for research.

Faculty

Junne Kamihara, MD, PhD
Instructor in Pediatrics
Harvard Medical School

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

The speaker attests that he is currently receiving grant/research support from Leo Pharma for a clinical trial and had received royalty from an advisory board.

                                                                             

Session date: 
Tuesday, March 30, 2021 - 8:00am to 9:00am
Location: 
Webinar Live
MA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.